Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

  • Post author:
  • Post published:October 18, 2025
  • Post category:

One in every ten thousand people in the USA have Huntington's Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingSustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

New Cell Lines for Huntington’s Disease

  • Post author:
  • Post published:October 18, 2025
  • Post category:

Huntington’s disease (HD) is a devastating neurodegenerative disease with a 1/10,000 disease risk that always leads to death. These numbers do not fully reflect the large societal and familial cost…

Continue ReadingNew Cell Lines for Huntington’s Disease

MSC engineered to produce BDNF for the treatment of Huntington’s disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

A team at UC Davis plans to use bone marrow derived mesenchymal stem cells to deliver a growth factor, called BDNF, to patients' brains in order to reduce the death…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease

Control of OCT4 abundance and function in human stem cells

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Research Objective Our work will reveal an essential pathway that establishes precise levels of the OCT4 transcription factor and protects stem cell identity despite genetic or environmental stress. Impact Our…

Continue ReadingControl of OCT4 abundance and function in human stem cells

RNA-directed therapy for Huntington’s disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Research Objective We develop a novel adeno-associated viral (AAV) vector-delivered RNA-targeting therapeutic for elimination of toxic RNA causative of Huntington’s disease. Impact There are no disease-modifying therapies for Huntington’s disease.…

Continue ReadingRNA-directed therapy for Huntington’s disease

Discovery of therapeutics for Huntington’s Disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Research Objective The objective of the proposed research is to perform 3 independent hESC-based screens to identify drug candidates for Huntington’s Disease. Impact There are currently no effective treatments for…

Continue ReadingDiscovery of therapeutics for Huntington’s Disease

hNSC-mediated delivery of ApiCCT1 as a candidate therapeutic for Huntington’s disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Research Objective The therapeutic candidate is a human Neural Stem Cell that secretes a protein, ApiCCT1, that aids in the prevention of disease phenotypes, for application in treatment of Huntington's…

Continue ReadinghNSC-mediated delivery of ApiCCT1 as a candidate therapeutic for Huntington’s disease

Genetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Continue ReadingGenetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease

Advanced Therapies and Stem Cells for Huntington’s disease

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Continue ReadingAdvanced Therapies and Stem Cells for Huntington’s disease

HD-CARE INAUGURAL SYMPOSIUM

  • Post author:
  • Post published:October 17, 2025
  • Post category:

Continue ReadingHD-CARE INAUGURAL SYMPOSIUM
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us